ZA968790B - Combination antiemetic therapy using NK-1 receptor antagonists. - Google Patents

Combination antiemetic therapy using NK-1 receptor antagonists.

Info

Publication number: ZA968790B
Authority: ZA; South Africa
Prior art keywords: combination; receptor antagonists; antiemetic therapy; antiemetic; therapy
Prior art date: 1995-10-20

Application number

ZA9608790A

Other languages

English (en)

Inventor

Susan F Gonsalves

Sandra L Silberman

John W Watson

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-20

Filing date

1996-10-18

Publication date

1998-04-20

1996-10-18 Application filed by Pfizer filed Critical Pfizer

1998-04-20 Publication of ZA968790B publication Critical patent/ZA968790B/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA9608790A 1995-10-20 1996-10-18 Combination antiemetic therapy using NK-1 receptor antagonists. ZA968790B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US572895P	1995-10-20	1995-10-20

Publications (1)

Publication Number	Publication Date
ZA968790B true ZA968790B (en)	1998-04-20

Family

ID=21717419

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9608790A ZA968790B (en)	1995-10-20	1996-10-18	Combination antiemetic therapy using NK-1 receptor antagonists.

Country Status (9)

Country	Link
EP (1)	EP0769300A3 (xx)
JP (1)	JPH09110721A (xx)
CN (1)	CN1151893A (xx)
AU (1)	AU700841B2 (xx)
CA (1)	CA2188227C (xx)
IL (1)	IL119418A (xx)
NZ (1)	NZ299606A (xx)
TW (1)	TW458774B (xx)
ZA (1)	ZA968790B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2149767T5 (es)	1991-09-20	2005-06-16	Glaxo Group Limited	Nuevo uso medico para antagonistas de taquiquininas.

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0360390A1 (en)	1988-07-25	1990-03-28	Glaxo Group Limited	Spirolactam derivatives
MX18467A (es)	1988-11-23	1993-07-01	Pfizer	Agentes terapeuticos de quinuclidinas
FI97540C (fi)	1989-11-06	1997-01-10	Sanofi Sa	Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
US5232929A (en)	1990-11-28	1993-08-03	Pfizer Inc.	3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
WO1992006079A1 (en)	1990-09-28	1992-04-16	Pfizer Inc.	Fused ring analogs of nitrogen containing nonaromatic heterocycles
AU652407B2 (en)	1991-01-10	1994-08-25	Pfizer Inc.	N-alkyl quinuclidinium salts as substance P antagonists
ATE154354T1 (de)	1991-02-11	1997-06-15	Merck Sharp & Dohme	Azabicyclische verbindungen, diese enthaltende pharmazeutische zubereitungen und ihre therapeutische verwendung
DK0573522T3 (da)	1991-03-01	1995-03-06	Pfizer	1-Azabicyclo(3,2,2)nonan-3-aminderivater
WO1992020661A1 (en)	1991-05-22	1992-11-26	Merck & Co., Inc.	N, n-diacylpiperazines
DE9290057U1 (de)	1991-05-22	1994-01-05	Pfizer Inc., New York, N.Y.	Substituierte 3-Aminochinuclidine
DK0587723T3 (da)	1991-05-31	1996-04-01	Pfizer	Quinuclidinderivater
ATE142199T1 (de)	1991-06-20	1996-09-15	Pfizer	Fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen
TW202432B (xx)	1991-06-21	1993-03-21	Pfizer
US5288730A (en)	1991-06-24	1994-02-22	Merck Sharp & Dohme Limited	Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy
IE72090B1 (en)	1991-07-05	1997-03-12	Merck Sharp & Dohme	Aromatic compounds pharmaceutical compositions containing them and their use in therapy
EP0593559A1 (en)	1991-07-05	1994-04-27	MERCK SHARP & DOHME LTD.	Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
JPH06509090A (ja)	1991-07-10	1994-10-13	メルク　シヤープ　エンド　ドーム　リミテツド	芳香族化合物、それらを含む組成物、及び治療におけるそれらの使用
WO1993001159A1 (en)	1991-07-10	1993-01-21	Merck Sharp & Dohme Limited	Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
WO1993004040A1 (en)	1991-08-20	1993-03-04	Merck Sharp & Dohme Limited	Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them
ES2149767T5 (es)	1991-09-20	2005-06-16	Glaxo Group Limited	Nuevo uso medico para antagonistas de taquiquininas.
CA2118704C (en)	1991-09-26	1997-01-21	John A. Lowe, Iii	Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists
HUT70741A (en)	1991-11-12	1995-10-30	Pfizer	Acyclic ethylenediamine derivatives as substance p receptor antagonists
DE4143345B4 (de)	1991-12-04	2007-03-22	Rieter Ingolstadt Spinnereimaschinenbau Ag	Drehteller einer Spinnereivorbereitungsmaschine
GB9201179D0 (en)	1992-01-21	1992-03-11	Glaxo Group Ltd	Chemical compounds
JP2656702B2 (ja)	1992-03-23	1997-09-24	ファイザー製薬株式会社	ペプチド性キヌクリジン
PT655996E (pt)	1992-08-19	2002-04-29	Pfizer	Benzilaminas substituidas contendo heterociclicos nao aromaticos contendo azoto
JP2656699B2 (ja)	1992-10-21	1997-09-24	ファイザー製薬株式会社	置換ベンジルアミノキヌクリジン
CA2150123C (en)	1992-12-10	2004-12-07	Harry R. Howard	Aminomethylene substituted non-aromatic heterocycles
DK0687268T3 (da)	1993-03-04	1998-10-12	Pfizer	Spiroazacykliske derivater som substans P-antagonister
GB9305718D0 (en)	1993-03-19	1993-05-05	Glaxo Group Ltd	Medicaments
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
GB9315808D0 (en)	1993-07-30	1993-09-15	Merck Sharp & Dohme	Therapeutic agents
GB9317987D0 (en) *	1993-08-26	1993-10-13	Glaxo Group Ltd	Chemical compounds
IS4208A (is)	1993-09-22	1995-03-23	Glaxo Group Limited	3-(tetrazólýl-benzyl)amínó-piperadidín afleiður
ES2120170T3 (es)	1994-01-13	1998-10-16	Merck Sharp & Dohme	Antagonistas azaciclicos gem-disustituidos de taquiquininas.
AU1462795A (en)	1994-01-28	1995-08-15	Merck Sharp & Dohme Limited	Aralkylamino substituted azacyclic therapeutic agents
PE45195A1 (es)	1994-03-03	1996-01-17	Boehringer Ingelheim Kg	Derivado de aminoacido, procedimiento para su preparacion y composicion farmaceutica que lo contiene
GB9525296D0 (en) *	1995-12-11	1996-02-07	Merck Sharp & Dohme	Therapeutic agents

1996
- 1996-07-16 TW TW085108626A patent/TW458774B/zh not_active IP Right Cessation
- 1996-10-14 IL IL11941896A patent/IL119418A/en not_active IP Right Cessation
- 1996-10-17 CN CN96112447A patent/CN1151893A/zh active Pending
- 1996-10-17 EP EP96307533A patent/EP0769300A3/en not_active Withdrawn
- 1996-10-18 JP JP8297370A patent/JPH09110721A/ja active Pending
- 1996-10-18 NZ NZ299606A patent/NZ299606A/en unknown
- 1996-10-18 CA CA002188227A patent/CA2188227C/en not_active Expired - Fee Related
- 1996-10-18 AU AU70279/96A patent/AU700841B2/en not_active Ceased
- 1996-10-18 ZA ZA9608790A patent/ZA968790B/xx unknown

Also Published As

Publication number	Publication date
NZ299606A (en)	2000-07-28
EP0769300A3 (en)	1999-11-24
MX9605030A (es)	1997-09-30
CA2188227A1 (en)	1997-04-21
CA2188227C (en)	2000-08-08
AU700841B2 (en)	1999-01-14
CN1151893A (zh)	1997-06-18
JPH09110721A (ja)	1997-04-28
TW458774B (en)	2001-10-11
IL119418A (en)	2001-07-24
IL119418A0 (en)	1997-01-10
AU7027996A (en)	1997-05-15
EP0769300A2 (en)	1997-04-23

Publication	Publication Date	Title
HU9603525D0 (en)	1997-02-28	Vironectin receptor antagonists
EP0673247A4 (en)	1996-05-01	FIBRINOGEN RECEPTOR ANTAGONISTS.
EP0667773A4 (en)	1996-09-25	FIBRINOGEN RECEPTOR ANTAGONISTS.
HU9601529D0 (en)	1996-07-29	Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
EP0810994A4 (en)	1998-05-06	FIBRINOGENIC RECEPTOR ANTAGONISTS
AU8374491A (en)	1992-03-12	Angiotensin II receptor antagonists
EP0912175A4 (en)	1999-09-08	FIBRINOGENIC RECEPTOR ANTAGONISTS
HU9503402D0 (en)	1996-02-28	Neurokinin receptor antagonists
AU7692996A (en)	1997-06-27	Receptor antagonists
ZA974234B (en)	1997-12-11	Adhesion receptor antagonists.
EP0763035A4 (en)	1997-10-01	ENDOTHELIN RECEPTOR ANTAGONISTS
EP0866705A4 (en)	1999-03-03	FIBRINOGENIC RECEPTOR ANTAGONISTS
ZA969775B (en)	1998-05-21	Endothelin receptor antagonists.
EP0885205A4 (en)	2002-11-27	FIBRINOGENIC RECEPTOR ANTAGONISTS
HU9503067D0 (en)	1995-12-28	Endotheline receptor antagonists
AU3276293A (en)	1993-07-28	Angiotensin II receptor antagonists
EP0885213A4 (en)	1999-04-28	FIBRINOGEN RECEPTOR ANTAGONISTS
HU9601176D0 (en)	1996-06-28	Adhesion-receptor antagonists
EP0796098A4 (en)	1998-04-29	FIBRINOGEN RECEPTOR ANTAGONISTS
EP0684823A4 (en)	1997-07-09	FIBRINOGEN RECEPTOR ANTAGONISTS.
EP0801650A4 (en)	1998-05-06	FIBRINOGEN RECEPTOR ANTAGONISTS
EP0766684A4 (en)	1997-07-16	ENDOTHELINE RECEPTOR ANTAGONISTS
ZA959434B (en)	1996-05-15	Adhesion receptor antagonists
EP0794779A4 (en)	1998-04-29	FIBRINOGENIC RECEPTOR ANTAGONISTS
HU9602127D0 (en)	1996-09-30	Endotheline receptor antagonists